NSEOutcome of Board Meeting4d ago · 3 Nov 2026, 06:59 pm
Outcome of Board Meeting
Arvee Laboratories (India) Limited · ARVEE
✦ AI SummaryResults
Arvee Laboratories (India) Limited has announced its unaudited financial results for the quarter ended September 30, 2026, and has also made several board-level appointments and resignations.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Attachments (1)
📄pdf
Download →
ARVEE_03112026185622_out.pdf
View document text
Arvee Laboratories (lndia) Limited. arvee
403, Entice Building, Opposite Jayantilal Park BRTS Bus Stop,
lskcon - Bopal Road, Ambli, Ahmedabad 380 058, Gujarat, lndia.
Phone: +91- 2717430479 I +91- 2717410819
LABORATORIES
e-mail: info@arveelabs.com, Website: www.arveelabs.com
CIN No. - L24231 GJ2012PLC06877 8.
Date: 3RD November, 2026
National Stock Exchange of lndia Limited
Mumbai
Subiect: Outcome of Board Meeting
Scrip Code: ARVEE lSlN : 1NE006201016
Dear Sir/Ma'am,
With reference to the above subject please find enclose herewith the outcome of Board
Meeting held today
a) Approved the Unaudited Standalone quarterly and half yearly results for the period ended
on 30th September,2026
b) Approved the Half yearly related party transactions
c)Taken on record Limited Review Report
d) Approved the Appointment of Mr. Shalin Bharat Chokshi as an Additional Director of the
Company.
e) Approved the Resignation of Mr. Saurin Ajitbhai Gandhi as Director of the Company
f) Approved the Appointment of Mr. Duttsagar Atulbhai Chavda as a Company Secretary of
the Company.
Resignation Letter of Mr. Saurin Ajitbhai Gandhi is enclosed herewith.
The Board meeting started at 3\ 30 p.m. and concluded at Sl I 5 p.m.
Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 read with Para A of Part A of Schedule lll is enclosed as an
Annexure.
Arvee Laboratories (!ndia) Limited. arvee
403, Entice Building, Opposite Jayantilal Park BRTS Bus Stop,
lskcon - Bopal Road, Ambli, Ahmedabad 380 058, Gujarat, lndia.
Phone: +91 - 27 17 430479 I +91 - 27 17 410819
LABORATORIES
e-mail: info@arveelabs.com, Website: www.arveelabs.com
Cl N No. L24231GJ201 2PLC06877 8.
Yours faithfully,
For, Arvee Laboratories (lndia) Limited
Managing Director
Shalin Sudhakarbhai Patel
DIN:01779902
Arvee Laboratories (lndia) Limited. arvee
403, Entice Building, Opposite Jayantilal Park BRTS Bus Stop,
lskcon - Bopal Road, Ambli, Ahmedabad 380 058, Gujarat, lndia.
Phone: +91 - 27 17 430479 I +91 - 27 17 410819
e'mail: info@arveelabs.com, Website: wwwarveelabs.com LABORATORIES
CIN No. . L24231 GJ2012PLC06877 8.
a) Appointment of Mr. Shalin Bharat Chokshi as Additional Director of the Company.
7 Reason for change viz. Appointment
appointment
2 Date of appointment 3'd November,2026
3 Brief Profile in case of Mr. Shalin Bharat Chokshi is a graduate in commerce
appointment and holds a degree in Masters of Professional
Accounting, Monash University, Australia. He has been
pivotal in bringing new international raw material
suppliers to the Company which has proved to be highly
cost beneficial to the company. At the same time he has
identified key consumers for Company's products in
the lnternational market. He has closely monitors
Company affairs and its functions.
4 Relation with Directors of the Nil
Company ( in case of
appointment
5 Shareholding in the Company Nil
b) Resignation of Mr. Saurin Ajitbhai Gandhi as Director of the Company.
1, Reason for change viz. Resignation
appointment / resignation
2 Date of appointment 3'd November,2026
3 Brief Profile in case of Not Applicable
appointment
4 Relation with Directors of the Nil
Company ( in case of
appointment
5 Shareholding in the Companv Nil
c) Appointment of Mr. Duttsagar Atulbhai Chavda as a Company Secretary of the Company
7 Reason for change viz.
appointment / Resignation
E6/il{0.
Arvee Laboratories (lndia) Limited. arVee
403, Entice Building, Opposite Jayantilal Park BRTS Bus Stop,
lskcon - Bopal Road, Ambli, Ahmedabad 380 058, Gujarat, lndia.
Phone: +91- 2717430479 I +91- 2717410819
e-mail: info@arveelabs.com, Website: www.arveelabs.com LABORATORIES
CIN No. - L24231 GJ2012PLCO6877 8.
2 Date of Appointment 3'd November,2026
3 Brief Profile in case of He has experience in Secretarial matters, listing
appointment matters. He is a member of lnstitute of Company
Secretaries of lndia
4 Relation with Directors of the Nil
Company ( in case of
appointment
5 Shareholding in the Company Nil
Arvee Laboratories (!ndia) Limited. arvee
403, Entice Building, Opposite Jayantilal Park BRTS Bus Stop,
lskcon - Bopal Road, Ambli, Ahmedabad 380 058, Gujarat, lndia
Phone: +91- 2717430479I +91- 2717410819
LABORATORIES
e-mail: info@arveelabs.com, Website: wvrnv.arveelabs.com
Cl N No. L24231 GJ2012PLC06877 8.
ARVEE LABORATORTES (rNDrA) LrMrrED
Cl N : 1242 3 lGJ 2OL2PLCO687 7 8
Registered Office:403, Entice, Nr. Jayantilal Park BRTS,
lskcon Bopal Road, Ambli, Ahmedabad - 380058
Tel : +91 -2717-430479 ll+91-27L7-410819; Website : www.arveelabs.com; Email lD : compliance@arveelabs.com
STATEMENT OF UNAUDITED FINANCIAL RESUTTS FOR THE QUARTER ENDED ON SEPTEMBER 30, 2025
(( in Lakhs, except per share data)
Quarter ended Half Year Ended Year ended
Particulars 30l09l2026 30l06l2026 301091202s 30l09l2026 30l09l2O2s 3Ll03l2026
Un-Audited Un-Audited Un-Audited Un-Audited Un-Audited Audited
7 Revenue from Operations 2,492.8L t,722.53 345.05 4,215.34 1,093.0s 3.\57.4t
2 Other lncome 33.94 18.09 22.96 52.03 39.83 58.11
3 Total Revenue (1+2) 2,s26.76 1,740.6L 368.01 4,267.37 1,132.88 3,219.52
4 Expenses
Cost of material consumed 1,,441.06 915.54 396.72 2,357.69 944.40 1,818.90
Changes in inventories of finished goods, work-in-
L40.43 207.83 (383.80) 348.26 (ss0.14) (3s2.s3
progress and stock-in-trade
mployee benefit Expenses 726.40 155 31 65.55 281,.72 233.L3 446.87
Finance Costs 9.59 6.49 4.38 16.08 8.72 23.48
Depreciation and amortisation expenses 32.90 32.27 30.29 65.17 59.70 72L.37
Other expenses 44t.93 193.19 254.44 635.t2 4s8.62 918.38
Total Expenses (4) 2,L92.31 1,51L,73 366.98 3,704.04 L,114.43 2,976.47
Protit / ([oss) before exceptional items and tax (1-
5 334.45 228.88 1.03 553.33 18.46 243.O4
6 Exceptional items
7 Prolit / (Loss) before tax (5-5) 334.45 228.88 1.03 s53.33 18.46 243.04
8 Tax expense
Current Tax 78.78 51.82 0.02 t29.87 0.s3 37.61
Deferred Tax 0.06 7.65 7.70 (47.19)
Profit I (Loss) for the period from continuing
9 255.61 169.41 1.01 425.76 L7.93 2s2.63
operations (7-8)
10 Profit / (Loss) from discontinued operations
11 Tax Expense of discontinued operations
Profit / (Loss) from discontinued operations (after
tax) (10-11)
13 Profit I (Loss) for the period (9+12) 255.51 L69.41 1.01 42s.76 L7.93 252.63
74 Other Comprehensive ncome
a. ltems that will not be reclassified to profit or loss
(Net of tax)
b. ltems that will be reclassified to profit or loss
(Net of tax)
Total Comprehensive lncome for the period
15 255.61 159.41 1.01 425.75 17.93 2s2.63
(13+14)
Paid-up equity share capital (Face Value of the
Share Rs. 10/- each) f-fi:! f1 ,-e f2 r- ii0 *0 : 1,102.00 1,102.00 1,102.00 1,102.00 1,102.00
l'lr
"A Ktr
8i ,Tg
\SEo-rccgDl
agfl
Arvee Laboratories (lndia) Limited. arvee
403, Entice Building, Opposite Jayantilal Park BRTS Bus Stop,
lskcon - Bopal Road, Ambli, Ahmedabad 380 058, Gujarat, lndia.
Phone: +91 - 27 17 430479 +91 - 27 17 410819
e-mail: info@arveelabs.com, Website: www.arveelabs.com LABORATORIES
CIN No. L24231 GJ2012PLC068778.
Earnings per equity share (for continuing
operation)
Basic 2.32 L.54 0.01 3.85 0.16 2.29
Diluted 2.32 7.54 0.01 3.86 0.16 2.29
Earnings per equity share (for discontinued
operation)
Basic
Diluted
Earnings per equity share (for continuing &
discontinued operation)
Basic 2.32 1.54 0.01 3.86 0.16 2.29
Diluted 2.32 t.54 0.01 3.86 0.16 2.29
Paid-up equity share capital (Face value of { 10
1,102.00 1,102.00 1,102.00 1,102.00 1,102.00 1,102.00
each)
Other Equity excluding Revaluation Reserve 2,701.78 2,446,18 2,O42.06 2,70t.78 2,042.06 2,276.77
Notes :
The aforesaid Financial Results for the quarter ended September 30, 2025 have been reviewed by the Audit Committee and subsequently
1 approved by the Board of Directors at its Meeting held on Tuesday, November 03,2026. The Statutory Auditors of the Company have carried out
a Limited Review of the aforesaid results.
The aforesaid Financial Results for the quarter ended September 30, 2025 have been prepared in accordance with Companies (lnd
[Showing first 8,000 characters — download PDF for full document]